PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#dexamethasone ×

UPDATED
Regulatorische Updates
25. Sept. 2026•1 Min. Lesezeit
FDA Approves Dexamethasone Sodium Phosphate Injection (ANDA 084282)
The FDA has approved ANDA 084282 for Dexamethasone Sodium Phosphate injectable, a prescription drug manufactured by Hikma and Civica with multiple NDC listings.
UPDATED
Regulatorische Updates
29. Aug. 2026•1 Min. Lesezeit
Watson Labs' Dexamethasone Sodium Phosphate Injection Discontinued (ANDA083702)
Watson Labs' injectable dexamethasone sodium phosphate (product 001) is listed as discontinued per FDA ANDA083702 filing.